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Abstract
Background: Type II diabetes has become a serious threat to human health in recent years. Among adults above 20 years
old in China, the prevalence rate of diabetes is 9.7%. Thus, it is imperative to study the mechanisms underlying type II
diabetes to develop effective therapeutic treatments.
Objective: To examine metabolic changes in a rat model of  type II diabetes and explore mechanisms underlying the
beneficial effects of traditional Chinese medicine (TCM) in this model. 120 rats were divided into four groups, including a
control group, a high-fat diet group (high-fat diet and streptozotocin injection), a TCM group (high-fat diet, streptozotocin
injection, followed by TCM administration), and a rosiglitazone maleate group (high-fat diet, streptozotocin injection,
followed by rosiglitazone maleate administration). Metabolites in urine samples from 1-3 weeks (time point 1) and 4-6
weeks (time point 2) of drug administration were compared by gas chromatography-mass spectrometry (GC-MS).
Results: Our results showed that in the high-fat diet group, at time point 2, the levels of  dihydroxybenzoic acid, L-ascorbic
acid, D-gluconic acid, octadecanoic acid, and glutaric acid in urine were significantly higher than at time point 1. In the TCM
group, at time point 2, the urine levels of  L-ascorbic acid were markedly lower than at time point 1.
Conclusion: Our studies demonstrated that examining urine metabolic changes provided important insights into the
mechanisms underlying type II diabetes as well as the therapeutic effects of TCM.
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Type II diabetes has become a serious threat to
human health in recent years. Among adults above
20 years old in China, the prevalence rate of diabetes
is 9.7% (male: 10.6%; females: 8.8%). The average
onset age has also decreased significantly1. Thus, it is
imperative to study the mechanisms underlying type
II diabetes to develop effective therapeutic
treatments.
Metabonomics, the study of metabolites and their
roles in various disease states, is a novel methodology
arising from the post-genomics era. In the last
decade, “metabonomics” had demonstrated
enormous potential in further detecting and
comprehending the aetiopathogenesis of many
diseases, including cardiovascular disorders and
diabetes2. Metabonomics is now recognized as an
independently and widely used technique for deriving
new biochemically based assays for disease diagnosis,
understanding the relationships between gene
function and metabolic control in health and disease,
and identifying combination biomarkers for disease3.
Nowadays Gas Chromatography (GC) is playing
an important role in the metabonomics research. 4, 5
Type II diabetes (DM2) is a typical metabolism
disorder disease with the very high frequency of 1.5–
2.5% in the Western hemisphere. Some of  the
changes in the concentrations of the metabolites are
detectable in blood serum and in urine even when
the diabetic patients are well controlled by therapy.
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These alterations are therefore inherently associated
with the disease. GC analysis has revealed a number
of path physiological changes to accompany
diabetes mellitus.
Traditional Chinese medicine (TCM) has been widely
used to treat type II diabetes 6, 7. Both clinical and
animal studies have provided important evidences 8.
This study established a rat model of type II
diabetes in which rats were fed with high-fat diet
for 6 weeks and then received intraperitoneal injection
of  streptozotocin, an inducer of  diabetes. Then we
employed gas chromatography-mass spectrometry
(GC-MS) to explore metabolite changes in the urine.
We also examined that how administration of  TCM
affects metabolites in the urine. Metabonomics
revealed a dynamic metabolic fingerprint in urine or
blood samples, and thus could provide important




A total of 120 8-week male Sprague Dawley (SD)
rats, weighting 220 ± 10 g, were purchased from
Vital River Lab Animal Technology Co., Ltd., Beijing,
China. Rats were kept in the animal center of Beijing
University of Chinese Medicine under standard
conditions (room temperature: 18-25°C, relative
humidity: 50-60%). Rats were habituated to the
environment for 1 week before the operation.
Food
Regular and high-fat rat foods were purchased from
Institute of  Zoology, Chinese Academy of  Sciences.
High-fat feed was composed of (by weight) 20%
lard, 10% sucrose, 23% casein, 0.3% methionine,
28% starch, 10% dextrin, 7.5% cellulose, 0.3%
choline, 0.1% multi-vitamin premix, and 0.8% multi-
mineral premix.
Chinese herbal formula
The Chinese herbal formula was composed of
Chinese 24g atractylodes rhizome, 24g largehead
atractylodes rhizome, 12g skullcap, and 12g salvia,
and was provided by Beijing University of Chinese
Medicineÿprepared the herbs from the effective
fraction, extracted by water and then extracted by
ethanol, followed by the strict standards. The Chinese
herbal formula was kept at 4°C. Rats in the TCM
group were given oral garage of 1 g/mL once daily
at 8 am. Rats in the western medicine group were
given oral garage about rosiglitazone maleate tablets
(Glaxosmithkline Holdings Inc.) ( dissolved at 0.2
mg/mL) once daily at 8 am. The dose for the
experimental study was calculated by considering
seven times clinical dose and its conversion to rat
dose was on the basis of body weight.
The four herbs were collected from TCM experts’
common view. They were authenticated by
Professor Guijun Zhang from Beijing University of
Chinese Medicine.
Reagents
Streptozotocin was purchased from Beijing Bangding
Taike Biotechnology Co., Ltd., China. Acetonitrile
(A996-4) was purchased from Fisher Scientific, USA.
Pyridine (110-86-1) and chloroform (67-66-3) were
from Mreda Technology Inc. USA, 17 carbon fatty
acid (H3500-5G), trimethylchlorosilane (386529), and
N-methyl-N-(trimethylsilyl)trifluoroacetamide
(394866) were purchased from Sigma, USA.
Equipment
Trace 2000/Trace DSQ gas chromatography-mass
spectrometer was purchased from Finnigan, USA.
High-fat diet model and medical treatment
In the high-fat diet group, rats were fed with high-
fat food for 6 weeks, and then received
intraperitoneal injection of streptozotocin (35 mg/
kg). In the control group, rats were fed with normal
diet for 6 weeks, and then received intraperitoneal
injection of 0.1M citric acid-sodium citrate buffer
(same dose). Four weeks after streptozotocin or
buffer injection, the plasma glucose level in tail vein
blood was tested in both groups. Only rats with
fasting blood glucose levels > 11.1 mmol/L were
included in the study 9.
A total of 59 rats underwent high-fat diet
reached the above standard. The rats were randomly
divided into four groups: a TCM group, a
rosiglitazone maleate group, a high-fat diet group,
and a control group. Rats in the TCM group received
4 mL of  traditional Chinese formula by oral garage.
Rats in the rosiglitazone maleate group received 1
mL of rosiglitazone maleate by oral garage. Rats in
both the high-fat diet group and the control group
received water by oral garage. For all the rats, oral
garage was performed once daily at 8 am and lasted
for 6 weeks.
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Urine collection
During the 6 weeks of  drug intervention, 24-h urine
samples were collected from the TCM group,
rosiglitazone maleate group, high-fat diet group, and
control group once every weekend. Urine samples
were collected from eight rats per group randomly,
with 1 mL of urine per rat, and were stored at -
80°C. Urine samples from the first 3 weeks were
grouped as time point 1, and the last 3 weeks, time
point 2. Since Type 2 diabetes is a kind of  metabolic
disorder, the urine is an important biological fluid
to study the metabolite change of the disease.
Gas chromatography-mass spectrometry
600 ìL of urine samples was mixed with 10µL of
internal standard (6 mg/mL of 17 carbon fatty acids)
and 400 µL of acetonitrile, vortexed for 1 min,
sonicated in an ultrasonic ice-bath for 10 min, and
centrifuged for 5 min at 18,000 r/min, 4°C. The
supernatant was transferred to a clean tube, dried
by nitrogen, mixed was 50 µL of methoxyamine
pyridine solution (15 mg/mL), and incubated at 30°C
for 2 h. 50µL of derivatization reagent (N-methyl-
N -
trimethylsilytrifluoroacetamide:trimethylchlorosilane
= 100:1, v/v) was added and the solution was
stratified for 1 h. The supernatant was transferred
into a micro sample tube for GC-MS analysis 10.
The parameters of GC-MS analysis were set
as follows. Split ratio: 1:1; injection volume: 0.5 µL;
injection port temperature: 280°C; and interface
temperature: 250°C. The temperature program was
adjusted as follows: first kept for 2 min at 80°C,
increased to 140°C at 10°C/min, increased to 240°C
at 4°C/min, increased to 280°C at 10°C/min, and
finally kept at 280°C for 3 min. Ion source
temperature: 200°C; carrier gas: high purity helium;
helium gas flow rate: 1.0 mL/min; ionization mode:
election impact; electron energy: 70 eV; and scan
range: 50-800 m/z 11.
Metabolite levels were reflected by the peak
area ratios of the analyte to internal standard in the
total ion flow diagram 12.
Statistical analysis
Data were analyzed by principal component analysis
(PCA) by SIMCA-P+ software (PCA principal
component analysis and PLS-DA . version 12.0.1,
Umetrics, Sweden). The basic statistics was
performed by using SPSS 17.0 Version. The
significance P<0.05 was computed by using
Independent t test between two groups.
Results
Total ion flow diagram
The total ion flow diagram of  the TCM group,
rosiglitazone maleate group, high-fat diet group, and
control group from time points 1 to 2 are shown in
figure 1.
Metabolite analysis
A total of nine endogenous metabolites were
identified in the urine samples with match factors
greater than 80% in the National Institute of
Standards and Technology mass spectral database.
Based on the retention time, these nine metabolites
Table 1: Urine metabolite analysis by GC-MS
# Retention Match Compound Potential Metabolite
Time Factor
(%)
1 14.97 86.55 Alpha-Alanine,N,N-bis(trimethylsilyl)-, trimethylsilyl ester Alanine
2 15.33 85.96 (R*,S*)-3,4-Dihydroxybutanoic acid tri TMS Dihydroxybenzoic acid
3 19.77 91.41 Pentanedioic acid,2-[(trimethylsilyl)oxy]-, Glutaric acid
bis(trimethylsilyl)ester
4 29.84 92.28 L-Ascorbic acid, 2-O-methyl-3,5,6-tris-O-(trimethylsilyl)- L-ascorbic acid
5 32.16 94.33 L-Ascorbic acid,2,3,5,6-tetrakis-O-(trimethylsilyl)- L-ascorbic acid
6 33.23 88.37 D-Gluconic acid,2,3,4,5,6-pentakis-O-(trimethylsilyl)-, D-gluconic acid
trimethylsilyl ester
7 34.3 91.49 Hexadecanoic acid,trimethylsilyl ester Palmitic acid
8 40.09 93.38 Octadecanoic acid,trimethylsilyl ester Octadecanoic acid
9 50.96 92.15 1-Monolinoleoylglycerol trimethylsilyl ether Glycerol
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contained alanine, dihydroxybenzoic acid, glutaric
acid, L-ascorbic acid, D-gluconic acid, palmitic acid,
octadecanoic acid, and glycerol (table 1).
Figure 1(1) Figure 1(2)





Figure 1. Total ion flow diagram.
Time point 1: TCM group (A), rosiglitazone maleate group (B), high-fat diet group (C), and control group (D).
Time point 2: TCM group (E), rosiglitazone maleate group (F), high-fat diet group (G), and control group (H).
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Treatment comparisons: high-fat diet
We first compared the time points 1 and 2 of  the
high-fat diet group. The PCA score plot (Figure 2A)
and loading diagram (figure 2B) showed that the
two groups (time points 1 and 2) separated from
each other along the t1 axis (except for the first
sample of time point 1). The first two principal
components could explain 67.2% of the total
variance, and the first four principal components
explained 85.7% of the total variance, covering most
of  the metabolite information. The PCA score plot
of the first two principal components demonstrated
that the samples were distributed in two regions,
with time point 1 samples on the left and time point
2 samples on the right.
Then we compared the high-fat diet group and
control group at the same time point. At time point
1, the PCA score plot (figure 2C) and loading
diagram (figure 2D) showed that the two groups
(the high-fat diet group and control group at time
point 1) separated from each other along the t2 axis.
The first two principal components could explain
67.4% of the total variance, and the first three
principal components explained 84.2% of the total
variance, covering most of the metabolite
information. The PCA score plot of  the first two
principal components demonstrated that the samples
were distributed in two regions, with the control
group on the top half and the high-fat diet group
on the bottom half.
At time point 2, the PCA score plot (figure
2E) and loading diagram (figure 2F) showed that
the two groups (the high-fat diet group and control
group at time point 2) separated from each other
along the t1 axis. The first two principal components
could explain 53.3% of the total variance, and the
first five principal components explained 85.8% of
the total variance, covering most of the metabolite
information. The PCA score plot of  the first two
principal components demonstrated that the samples
were distributed in two regions, with the control
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Figure 2E Figure 2F
Figure 2G Figure 2H
Figure 2I Figure 2J
Figure 2. PCA score plot and loading diagram.
Comparisons between time points 1 and 2 of the high-fat diet group: PCA score plot (A) and loading diagram (B).
Comparisons between the high-fat diet group and control group at time point 1: PCA score plot (C) and loading diagram
(D). Comparisons between the high-fat diet group and control group at time point 2: PCA score plot (E) and loading
diagram (F). Comparisons between time points 1 and 2 of the TCM group: PCA score plot (G) and loading diagram (H).
Comparisons between time points 1 and 2 of the rosiglitazone maleate group: PCA score plot (I) and loading diagram (J).
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Treatment comparisons: drug administration
We further compared the time points 1 and 2 of  the
TCM group. The PCA score plot (Figure 2G) and
loading diagram (figure 2H) showed that the two
groups (time points 1 and 2) separated from each
other along the t2 axis. The first two principal
components could explain 49.0% of the total
variance, and the first five principal components
explained 86.9% of the total variance, covering most
of  the metabolite information. The PCA score plot
of the first two principal components demonstrated
that the samples were distributed in two regions,
with time point 1 samples on the top half and time
point 2 samples on the bottom half.
We then compared the time points 1 and 2 of
the rosiglitazone maleate group. The PCA score plot
(figure 2I) and loading diagram (figure 2J) showed
that the two groups (time points 1 and 2) separated
from each other along the t1 axis. The first two
principal components could explain 72.5% of the
total variance, and the first three principal
components explained 87.2% of the total variance,
covering most of  the metabolite information. The
PCA score plot of the first two principal
components demonstrated that the samples were
distributed in two regions, with time point 1 samples
on the left and time point 2 samples on the right.
Metabolite comparisons
No difference in metabolites was observed at time
point 1 among the four treatment groups. At time
point 2, in the high-fat diet group, the levels of
dihydroxybenzoic acid, L-ascorbic acid (29 min), D-
gluconic acid, alanine, glutaric acid and octadecanoic
acid were higher than those in the control group (P
< 0.05 or P < 0.01, table 2). In the TCM group, at
time point 2, the levels of L-ascorbic acid (29 min)
were lower than those at time point 1 (P < 0.05,
table 2). In the high-fat diet group, at time point 2,
the levels of dihydroxybenzoic acid, L-ascorbic acid
(29 min), D-gluconic acid, octadecane acid, and
glutaric acid were higher than those at time point 1
(P < 0.05 or P < 0.01, table 2). The metabolites
were initially discovered by this experiment.
Table 2: Urine metabolite comparisons
Treatment Alanine Glutaric Acid L-ascorbic           L-ascorbic
Acid (29 min) Acid (32 min)
Time TCM 0.42±0.09 8.97±5.45 4.71±5.68
point 1 Rosiglitazone maleate 3.38±0.15
High-fat diet 1.30±0.30 0.410.02
Control 2.28±1.75 1.821.14
Time TCM 7.12±3.88 1.851.33‘“ 2.64±0.27
point 2 Rosiglitazone maleate 15.39±1.54 3.15±1.40‘“
High-fat diet 3.53±0.75* 68.6224.97**‘“‘“ 14.53±1.05**‘“‘“
Control 1.56±0.48 13.126.10 3.89±1.83 2.97±1.78
Note: *: P < 0.05 vs. the control group; **: P < 0.01 vs. the control group; ‘“: P < 0.05 between time points 1
and 2; and ‘“‘“: P < 0.01 between time points 1 and 2.
Discussion
Our study compared urine metabolites 1-3 weeks
or 4-6 weeks of drug administration in a rat model
of  diabetes. Our results demonstrated that at time
point 1, in the high-fat diet group, the levels of
dihydroxybenzoic acid, L-ascorbic acid (29 min), D-
gluconic acid, alanine, glutaric acid, and octadecanoic
acid were higher than those in the control group. In
the high-fat diet group, at time point 2, the levels of
dihydroxybenzoic acid, L-ascorbic acid (29 min), D-
gluconic acid, octadecanoic acid, and glutaric acid
were higher than those at time point 1. The increase
in L-ascorbic acid levels might reflect the triggering
of anti-oxidation defense in response to the increased
oxidation level in the rat model of  diabetes.
Octadecanoic acid, a stearic acid, belongs to saturated
fatty acids and was found in some vegetable oils
and animal fats. An increase in the levels of  saturated
fatty acids may raise the blood cholesterol level,
promote resistance to insulin and other hormones,
and cause hyperglycemia and other metabolic
disorders. As recorded in the Kyoto Encyclopedia
of  Genes and Genomes, abnormalities in alanine
levels are common in metabolic disorders. Therefore,
the increase in alanine levels observed in our study
may provide an important target for future studies.
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Table 3: Urine metabolite comparisons
Treatment Glycerol Dihydroxy- Palmitic D-gluconic Octadecanoic
benzoic Acid Acid Acid Acid
Time TCM 0.78±1.03 3.482.81 1.91±1.45 8.09±5.92 2.28±1.35
point 1 Rosiglitazone maleate 3.23±0.15 8.52±9.48
High-fat diet 0.37±0.13 0.83±0.53 0.21±0.07
Control 0.17±0.25 3.33±1.12 2.23±0.93 3.73±2.27 2.02±1.01
Time TCM 2.35±1.36 8.30±8.21
point 2 Rosiglitazone maleate 2.48±0.73 4.62±2.91
High-fat diet 7.21±1.32*³%³% 56.045.03**³%³% 3.32±1.07*³%³%
Control 3.09±1.33 6.57±3.79 1.18±0.63
Note: *: P < 0.05 vs. the control group; **: P < 0.01 vs. the control group; ³%: P < 0.05 between time points
1 and 2; and ³%³%: P < 0.01 between time points 1 and 2.
Our results also suggested that it is a good
strategy to reveal how TCM works in vivo by
following metabolic changes in rats Under TCM
administration, at time point 2, the L-ascorbic acid
levels in the rat urine (29 min) were lower than at
time point 1. This decrease might be related to the
fact that the TCM could reduce oxidative stress in
the rat model of diabetes 13, 14. Meanwhile, in the
urine of the TCM group at time point 2, a few
metabolites disappeared, including alanine, palmitic
acid, octadecanoic acid, and glycerol, and several
metabolites emerged, such as L-ascorbic acid (32
min), which suggested that TCM might enhance the
antioxidant function of  the body. In addition, both
stearic acid and palmitic acid levels decreased,
indicating that TCM might improve lipid
metabolism. TCM might reduce high blood glucose
levels by improving lipid metabolism or reducing
insulin resistance. The decrease in alanine levels under
TCM administration suggested that TCM might
affect amino acids metabolic pathways and thus
improve metabolic disorders.
GC-MS was mainly used in plant
metabonomics 15. In order to apply GC-MS analysis,
samples need to undergo the derivatization process
to increase stability and volatility. Therefore, GC-
MS analysis is limited to volatile substances, and
cannot be used to analyze thermal unstable
substances, such as lipid membrane, or metabolites
of  high molecular weight. In this study, we used GC-
MS to analyze changes in urine metabolites in a rat
model of  diabetes. In future studies, other
metabonomics technology can be incorporated to
examine more metabolites and further explore the
mechanisms underlying diabetes. Another interesting
issue is to study whether similar metabolic changes
also exist in other animal models of  type II diabetes.
Future studies can be strengthened in two
aspects. First, the sample size could be increased.
Second, the condition of diabetes could be
aggravated to facilitate the detection of  differences
in metabolites. In addition, under mild diseases,
difference in metabolites could be masked when
urine samples that contain the final metabolites are
examined. Future research can also employ blood
metabonomics to search biomarkers closely related
to disorders in sugar, fat, and protein metabolism.
Other technologies in system biology, including
proteomics and genomics, can also be applied to
study different syndromes of  type II diabetes.
Conclusion
Our results showed that in the high-fat diet group,
at time point 2, the urine levels of dihydroxybenzoic
acid, L-ascorbic acid, D-gluconic acid, octadecanoic
acid, and glutaric acid were significantly higher than
at time point 1. In the TCM group, at time point 2,
the urine levels of L-ascorbic acid were markedly
lower than at time point 1. Our studies demonstrated
that examining urine metabolic changes provided
important insights into the mechanisms underlying
type II diabetes as well as the therapeutic effects of
TCM.
According to former research 16, taking in less sugar
and lat, and adding more aerobic exercise can reduce
the morbidity of type II diabetes greatly in daily life.
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